Hlib Chabaniuk

PG stock weekly forecast: rebound odds stay low as resistance at $145.28 caps recovery attempts

PG stock weekly forecast: rebound odds stay low as resistance at $145.28 caps recovery attempts
Procter & Gamble slips 1.68% this week

Shares of The Procter & Gamble Company (PG) are trading near $144 after sliding about 2% over the past week as recent weakness has pushed the stock into oversold conditions. The decline has been led by a confluence of soft sentiment and corporate action, setting up a cautious mood for the days ahead.

PG price prediction
24H -0.15%
$161.3
48H 0.17%
$161.82
7D -0.93%
$160.04
1M 9.83%
$177.42
3M 5.19%
$169.92
6M 6.91%
$172.71
12M 6.86%
$172.62
Current price: $161.54 0.9500 0.59%
Closed 10/30
Daily range 161.07 Arrow from to Icon 163.57
Weekly range 157.40 Arrow from to Icon 163.57
Loading...

Highlights

  • Shares of Procter & Gamble fell to $143.92, trading below all major moving averages and facing long-term bearish pressure.
  • Price remains constrained within a narrow daily range as volatility reached 2.88% over the past week.
  • Shares are expected to consolidate between $142.04 and $148.2 over five days, with an 80% probability of further downside unless resistance at $145.66 is reclaimed.

Acquisition plans and restructuring drive sentiment as earnings approach

Procter & Gamble announced an agreement to acquire Thorne, a practitioner-channel supplement brand, for $3.8 billion, according to Nutritional Outlook. Kalkine Media noted that PG shares traded steadily ahead of its upcoming fiscal first-quarter earnings due in late October. Both The Motley Fool and Morningstar highlighted ongoing dividend growth and capital return priorities, while worldreview1989.com reported a restructuring program with up to $1.6 billion in expected pre-tax costs over the next two years.

Procter & Gamble Company asset chart
Procter & Gamble Company price dynamics. Source: TradingView.

Bullish momentum lags as PG price action stays below all key averages

On the daily chart, Procter & Gamble exhibits a contained move within a narrow range, as volatility over the past week reached 2.88%. Momentum signals show a mixed picture: the Stochastic RSI is in oversold territory at 0, while the MACD leans bullish with a "buy" reading, but price action remains weighed down below all key averages. With nearest resistance at $145.28 coinciding with the weekly low and the Ichimoku Kijun at $145.66 acting as resistance, upside movement appears capped in the short term. The setup suggests that bears hold the advantage pending a strong reaction from these levels.

Downside risk dominates in the coming week unless resistance breaks

Over the next five trading days, Procter & Gamble is expected to trade between $142.04 and $148.2. There is a very low probability of an increase (less than 20%) and a very high probability of a decrease (more than 80%). The base case is consolidation below resistance at $145.28, with the bullish scenario requiring a sustained move above $145.66, while a bearish break below $142.04 would signal further downside.

Jainam Mehta, market strategist, notes that shares of Procter & Gamble have retreated to $144 this week, weighed by soft sentiment and restructuring headlines despite ongoing dividend growth. He sees technical signals in conflict — with the Stochastic RSI deeply oversold but price still unable to reclaim levels above $145.28, and the Ichimoku Kijun at $145.66 acting as a near-term ceiling. Recent acquisition news and the restructuring plan add to the cautious tone, keeping the stock in a tight range. "Unless we see a strong move above $145.66, I expect bears to maintain short-term control and am watching for any contrarian bounce from these oversold conditions."

Earlier, analysts noted that Procter & Gamble’s share price was consolidating as technical indicators suggested mixed momentum. The current move below key trend levels signals a shift in control to sellers, making a break under $142.04 a pivotal downside risk to monitor in the immediate term.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.